deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT04201821

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women (FMT for FI)

Fecal Microbial Transplantation (FMT) For the Treatment of Fecal Incontinence in Women

Sponsor: University of Pennsylvania

Updated 18 times since 2020 Last updated: Jun 11, 2024 Started: Jan 14, 2021 Primary completion: Jan 18, 2023 Completion: Jan 18, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative reasons

This PHASE1/PHASE2 trial investigates Fecal Incontinence and is currently terminated or withdrawn. University of Pennsylvania leads this study, which shows 18 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2020 – ~Apr 2020 · 3 months · monthly snapshot~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2022 · 13 months · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Oct 2022 · 30 days · monthly snapshot~Oct 2022 – ~Feb 2023 · 4 months · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshot~Jul 2023 – ~Dec 2023 · 5 months · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

18 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  3. Jan 2024 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Dec 2023 — Jan 2024 [monthly]

    Terminated PHASE1_PHASE2

  5. Jul 2023 — Dec 2023 [monthly]

    Terminated PHASE1_PHASE2

    Status: Active Not RecruitingTerminated

Show 13 earlier versions
  1. Feb 2023 — Jul 2023 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: RecruitingActive Not Recruiting

  2. Oct 2022 — Feb 2023 [monthly]

    Recruiting PHASE1_PHASE2

  3. Sep 2022 — Oct 2022 [monthly]

    Recruiting PHASE1_PHASE2

  4. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE1_PHASE2

  5. Apr 2022 — Jul 2022 [monthly]

    Recruiting PHASE1_PHASE2

  6. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE1_PHASE2

  7. Feb 2021 — Mar 2022 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet RecruitingRecruiting

  8. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  9. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  10. Aug 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  11. Jun 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  12. Apr 2020 — Jun 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

  13. Jan 2020 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Pennsylvania
Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations